Log in to search using one of your social media accounts:

 

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Science - The Huffington Post - December 28, 2016 Category: Science Source Type: news

Carrie Fisher's Death Highlights The Reality Of Heart Disease In Women
Carrie Fisher died early Tuesday morning, four days after suffering a heart attack on a flight from London to Los Angeles. The actress and author, best known for her iconic role as Princess Leia in the “Star Wars” franchise, was 60 years old.  Experts say that Fisher’s death highlights an important reality about heart disease: It is the leading cause of death among men and women alike in the U.S. While heart disease encompasses many different conditions, a heart attack occurs when coronary arteries become blocked and oxygenated blood can’t reach the heart. About 735,000 Americans have hea...
Source: Healthy Living - The Huffington Post - December 28, 2016 Category: Consumer Health News Source Type: news

Biomarkers Predict Rituximab Response in RA (CME/CE)
(MedPage Today) --'A further step towards the goal of personalized medicine'in rheumatoid arthritis (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - December 28, 2016 Category: Geriatrics Source Type: news

What is rheumatoid arthritis? Chronic condition is caused by your OWN immune system
RHEUMATOID arthritis is a long-term condition that causes pain, swelling and stiffness in the joints and mainly affects the hands feet and wrists. (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2016 Category: Consumer Health News Source Type: news

Migraine drugs may repeat rheumatoid arthritis success
(Reuters) - Nearly two decades ago, several drugs to treat rheumatoid arthritis hit the shelves in rapid succession, opening up a huge market for the treatment of the autoimmune joint disorder. (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Olumiant (baricitinib) Oral Treatment for Rheumatoid Arthritis
Information regarding Olumiant (baricitinib) for the treatment of adults with moderate to severe active rheumatoid arthritis (Source: Disabled World)
Source: Disabled World - December 22, 2016 Category: Disability Tags: Pharmaceutical - Drug Information Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Science - The Huffington Post - December 21, 2016 Category: Science Source Type: news

The Secret To Treating Autoimmune Disease May Lie In The Gut
An estimated 50 million Americans ― that’s 20 percent of the general population ― suffer from autoimmune diseases like lupus, multiple sclerosis or rheumatoid arthritis, and many experts say that number is rising at an alarming rate.  Autoimmunity occurs when the immune system begins attacking the body’s healthy tissue as if it were an outside invader, leading to chronic inflammation. We still don’t know much about what causes the immune system to go haywire, or how to effectively treat it. But new research suggests that the gut microbiome ― the community of trillions of “g...
Source: Healthy Living - The Huffington Post - December 21, 2016 Category: Consumer Health News Source Type: news

CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More CHMP Backs Baricitinib, Lifmior for Plaque Psoriasis and More
The EMA's CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Nurses Headlines)
Source: Medscape Nurses Headlines - December 19, 2016 Category: Nursing Tags: Rheumatology News Alert Source Type: news

Discovery's Edge: Linking gut bacteria to Rheumatoid Arthritis
The cause of rheumatoid arthritis, a systemic autoimmune disease, is unknown. But certain genes and environmental factors, such as smoking, are linked to the disease process. Now Mayo Clinic research suggests a new link: the composition of gut microbes. Veena Taneja, Ph.D., an immunologist at Mayo Clinic?s Center for Individualized Medicine, recently demonstrated a relationship [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 19, 2016 Category: Databases & Libraries Source Type: news

Gum disease bug linked to rheumatoid arthritis
Conclusions This research aimed to investigate a possible bacterial origin of rheumatoid arthritis and found one potential candidate – Aggregatibacter actinomycetemcomitans (Aα). It seems these bacteria could cause the high levels of citrullinated proteins which are known to trigger an immune reaction in people with rheumatoid arthritis. However, it's important to put these findings into the right context. Though antibodies against citrullinated proteins, anti-cyclic citrullinated peptide (anti-CCP), are one of the possible diagnostic findings in people with rheumatoid arthritis – not everyone w...
Source: NHS News Feed - December 19, 2016 Category: Consumer Health News Tags: Medical practice Source Type: news

CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis CHMP Backs Baricitinib, Lifmior for Rheumatoid Arthritis
The EMA's CHMP recommended baricitinib for rheumatoid arthritis and Lifmior for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, and plaque psoriasis.International Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 16, 2016 Category: Dermatology Tags: Rheumatology News Alert Source Type: news

Brushing your teeth could prevent arthritis, experts say
The discovery by researchers at Johns Hopkins University adds to evidence that rheumatoid arthritis is linked with dental health, a theory that has been suspected for a long time. (Source: the Mail online | Health)
Source: the Mail online | Health - December 16, 2016 Category: Consumer Health News Source Type: news

Brush teeth to beat Arthritis: Bugs that cause gum disease linked to rheumatoid arthritis
BRUSHING your teeth could help ward off the agony of rheumatoid arthritis, according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - December 16, 2016 Category: Consumer Health News Source Type: news

New partnership forms to accelerate arthritis therapy
A new partnership, named the M40 alliance, has been launched to accelerate the development of novel treatments for arthritis. The new venture is supported by a£7 million investment from the Kennedy Trust for Rheumatology Research.The M40 alliance will develop a network of consultants, nurses and clinical researchers in clinical units along the M40 corridor, based on a partnership between the Universities of Oxford and Birmingham, with other hubs in the area also involved. It will harness the existing research strengths of both universities in order to accelerate the development and testing of new therapies for patien...
Source: Arthritis Research UK - December 16, 2016 Category: Rheumatology Source Type: news

Germ may link gum disease and rheumatoid arthritis
Randy Dotinga, HealthDay News A specific germ may help explain the long-noticed connection between gum disease and rheumatoid arthritis, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 15, 2016 Category: Consumer Health News Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
Study may offer new insight into the cause of the joint disorder Source: HealthDay Related MedlinePlus Pages: Bacterial Infections, Gum Disease, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 15, 2016 Category: Consumer Health News Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
THURSDAY, Dec. 15, 2016 -- A specific germ may help explain the long-noticed connection between gum disease and rheumatoid arthritis, a new study suggests. The discovery might also point to the potential origins of the painful joint illness. " If... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 15, 2016 Category: Journals (General) Source Type: news

Could a Germ Link Gum Disease, Rheumatoid Arthritis?
Title: Could a Germ Link Gum Disease, Rheumatoid Arthritis?Category: Health NewsCreated: 12/15/2016 12:00:00 AMLast Editorial Review: 12/15/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - December 15, 2016 Category: Rheumatology Source Type: news

Researchers add to evidence that common bacterial cause of gum disease may drive rheumatoid arthritis
New evidence suggests that a bacterium known to cause chronic inflammatory gum infections also triggers the inflammatory “autoimmune” response characteristic of chronic, joint-destroying rheumatoid arthritis (RA). The new findings have important implications for prevention and treatment of RA, say the researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 14, 2016 Category: Science Source Type: news

Invisible symptoms impact rheumatoid arthritis patients' lives, hinder diagnosis
(Health Union) Rheumatoid Arthritis In America 2016, a national survey by Health Union of more than 3,100 individuals with rheumatoid arthritis (RA), reveals that initial symptoms are often invisible to others, with respondents experiencing more than six on average. Among respondents, receiving a diagnosis often proved difficult with the average time between initial symptoms and diagnosis spanning four years. In addition, respondents feel stigmatized for often not looking sick and the unpredictable nature of the health condition. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 14, 2016 Category: Global & Universal Source Type: news

Workplace adjustments 'can help rheumatoid arthritis patients return to work'
Workplaces could be doing more to adjust their practices and provide greater flexibility in order to help rheumatoidarthritis patients return to work. This is according to a new study from Lancaster University and the Arthritis Research UK-MRC Centre for Musculoskeletal Health and Work, which aimed to offer a different viewpoint on sickness presenteeism, or the practice of continuing to work despite illness. A strong desire to work despite rheumatoid arthritis Generally speaking, sickness presenteeism is seen as having negative consequences for businesses and individuals alike, yet equally there is a perception that return...
Source: Arthritis Research UK - December 14, 2016 Category: Rheumatology Source Type: news

Toward New Treatment Targets in Rheumatoid Arthritis Toward New Treatment Targets in Rheumatoid Arthritis
From the ACR meeting in Washington, DC, Dr Lionel Ivashkiv discusses his research into promising new treatment approaches in inflammatory arthritis.Hospital for Special Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2016 Category: Consumer Health News Tags: Rheumatology Expert Interview Source Type: news

One in five worried about being fit enough to work next year
Results of a new survey released today have revealed that Great Britain is a nation of 'put up and shut up' when it comes to workplace health.Over 2,000 people were questioned about their attitudes and experience regarding health and the workplace. Results showed that:1 in 5 (20%) of people are worried they won't be fit enough to continue working in the next year.39% don't feel confident discussing their workplace health with their employer.A third of people (33%) with a long-term condition felt their colleagues don't understand the impact of their condition.Over 1 in 7 (15%) wouldn't disclose a long-term health ...
Source: Arthritis Research UK - December 8, 2016 Category: Rheumatology Source Type: news

Tocilizumab in RA With Inadequate Response to Methotrexate Tocilizumab in RA With Inadequate Response to Methotrexate
Does the addition of or switch to tocilizumab provide any additional benefits for rheumatoid arthritis patients who do not sufficiently respond to methotrexate alone?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Adverse Events of Glucocorticoids During Treatment of RA Adverse Events of Glucocorticoids During Treatment of RA
What do we know about the adverse effects of glucocorticoids in rheumatoid arthritis -- and how are they best managed?Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 7, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Updating Systematic Reviews: A PCORI Virtual Multi-Stakeholder Workshop on Drug Therapy for Rheumatoid Arthritis in Adults
Monday, December 12, 2016 - 10:00 am to 12:00 pm EST (Source: HSR Information Central)
Source: HSR Information Central - December 6, 2016 Category: Global & Universal Source Type: news

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug
Swiss Biotech firm Novimmune has entered into an option and licence agreement with Roche company Genentech to develop and commercialise its anti-toll-like receptor 4 (TLR4) monoclonal antibody, NI-0101, to treat rheumatoid arthritis and other auto-im … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - December 6, 2016 Category: Pharmaceuticals Source Type: news

Nerve Treatment When Drugs Fail
To help migraines, rheumatoid arthritis and other conditions, scientists try stimulating the vagus nerve, the same part of the nervous system activated by breathing exercise during meditation. (Source: WSJ.com: Health)
Source: WSJ.com: Health - December 5, 2016 Category: Pharmaceuticals Tags: FREE Source Type: news

Methotrexate ‘ Dramatically ’ Underused for RA Methotrexate ‘ Dramatically ’ Underused for RA
Methotrexate, the"anchor" drug for rheumatoid arthritis (RA), is"dramatically underutilized in clinical practice," researchers report.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - December 1, 2016 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Choosing a Management Strategy in RA Choosing a Management Strategy in RA
Drs Paget and Bykerk discuss the current data on treatment timing, disease modification, and comorbidities in rheumatoid arthritis.Hospital for Special Surgery eAcademy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 30, 2016 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

Can an app improve mental and physical health support for people with arthritis?
In partnership withMQ: Transforming Mental Health, we are proud to announce that Dr Sam Norton from King’s College London has won the 2016 Arthritis Research UK MQ Fellows award, to develop a new app aiming to explore mental and physical health support for people with arthritis.In the UK over 290,000 people live with rheumatoid arthritis, a condition that causes joint inflammation, pain, stiffness and fatigue. Around a third of these people also experience a mental health condition.Current drug treatments for rheumatoid arthritis can be helpful, but around 40% of people still experience ongoing pain, fatigue and ment...
Source: Arthritis Research UK - November 29, 2016 Category: Rheumatology Source Type: news

Staying on DMARDs Through Surgery Doesn't Boost Infection Risk Staying on DMARDs Through Surgery Doesn't Boost Infection Risk
Patients with rheumatoid arthritis (RA) on disease-modifying antirheumatic drug (DMARD) therapy who need surgery don't have to stop the medication in the perioperative period, according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 28, 2016 Category: Surgery Tags: Rheumatology News Source Type: news

New fibroblast study offers insights in rheumatoid arthritis treatment
This study focused on synovial fibroblasts, which make up part of the connective tissue around human joints. It is known that inrheumatoid arthritis, these cells cause damage by invading and attacking the cartilage and bone around the joint; however, this research offered evidence that there may be two distinct types of synovial fibroblast, which was not previously known. These two types were categorised by specific cell surface markers, PDPN and CD248, and it was shown that the part closest to the cartilage tended to contain the invasive PDPN-type fibroblasts that cause cartilage damage, while the part that was further aw...
Source: Arthritis Research UK - November 25, 2016 Category: Rheumatology Source Type: news

Fibroblasts could provide new target for treatment of rheumatoid arthritis
A new study reveals the key role of different types of fibroblast cells in the development of rheumatoid arthritis (RA), opening up a new avenue for research into treatment of the disease. Synovial Fibroblasts (SFs) are cells that make up part of the connective tissue, or synovium, around human joints. In RA patients, SF cells cause damage by invading and attacking the cartilage and bone around the joint. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 23, 2016 Category: Science Source Type: news

Novel Algorithms for the Use of US in the Management of RA Novel Algorithms for the Use of US in the Management of RA
These new algorithms will help provide guidance on the effective use of ultrasound in the diagnosis and management of rheumatoid arthritis.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Fibroblasts could provide new target for treatment of rheumatoid arthritis
(University of Birmingham) A study led by researchers at the University of Birmingham reveals the key role of different types of fibroblast cells in the development of rheumatoid arthritis, opening up a new avenue for research into treatment of the disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 23, 2016 Category: Biology Source Type: news

Maternal Rheumatoid Arthritis Linked to Epilepsy in Offspring Maternal Rheumatoid Arthritis Linked to Epilepsy in Offspring
A new study suggests autoimmunity factors present in the mother could be involved in some types of childhood epilepsy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 22, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

The promise of precision medicine for rheumatoid arthritis
In a new study, a Yale-led research team identified the mechanism of a gene that raises the risk of severe rheumatoid arthritis in susceptible individuals. The finding may lead to the development of treatment based on the genetic profiles of arthritis patients, the researchers said. (Source: Yale Science and Health News)
Source: Yale Science and Health News - November 21, 2016 Category: Universities & Medical Training Tags: Yale News Source Type: news

Make the Diagnosis: Nerve Concern
(MedPage Today) -- Case Findings: A 63-year-old left-handed male patient presents with tingling in both hands, particularly the left hand. He has struggled to sleep for the past week; after laying down to read, his hand begins to tingle. He reports the tingling only while lying down, he has no symptoms when sitting or standing, and the symptoms resolve quickly once he sits up. He reports symptoms across the whole hand (front and back), but more on the palm than the fingers. The tingling involves all fingers, but is less pronounced on the thumb. There is no muscle weakness, coolness, or discoloration. He reports no swelling...
Source: MedPage Today Rheumatology - November 21, 2016 Category: Rheumatology Source Type: news

9 Unusual Health and Fitness Trends to Try This Winter
Conclusion If you're tired of same old workouts and routines, some unusual health and fitness trends will help you stay fit and have fun this winter. With the trends from this article, winter doesn't have to be the "weight gain" season. Plus, it's a great way to do something useful on cold winter days when you don't feel like going to the gym. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 17, 2016 Category: Consumer Health News Source Type: news

Missing links that connect human DNA variation with disease discovered
Scientists have discovered the hidden connections in our genomes that contribute to common diseases. Using a pioneering technique, the results are beginning to make biological sense of the mountains of genetic data linking very small changes in our DNA sequence to our risk of disease. Discovering these missing links will inform the design of new drugs and future treatments for a range of diseases, including rheumatoid arthritis and other types of autoimmune disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - November 17, 2016 Category: Science Source Type: news

Genetic Signatures Predict Response to Treatment for RA Genetic Signatures Predict Response to Treatment for RA
The identification of three genetic signatures that predict how patients with rheumatoid arthritis will respond to therapy holds promise for personalized medicine, but replication studies are needed.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Medical News Today: Maternal rheumatoid arthritis linked to childhood epilepsy
New research examines the link between mothers and fathers with rheumatoid arthritis and the risk of their children developing epilepsy. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 17, 2016 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

Genetic markers 'could help predict response to rheumatoid arthritis therapies'
A number of genetic markers have been identified that could help predict treatment responses among people with rheumatoidarthritis. Led by Queen Elizabeth University Hospital in Glasgow and presented at the latest annual meeting of the American College of Rheumatology and the Association of Reproductive Health Professionals, the research has offered insights into new methods for testing patients to ensure they receive therapies that will work for them most effectively. How genes can predict responses to common therapies The study looked at data from 241 patients involved in a clinical trial called ORBIT, with the aim of fi...
Source: Arthritis Research UK - November 17, 2016 Category: Rheumatology Source Type: news

New Phase 3 Monotherapy Study of Sirukumab Versus Humira ® And Sirukumab Data In An Anti-Tnf Refractory Population Reported In The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
Anti-Interleukin-6 Monoclonal Antibody Sirukumab Efficacy and Safety Findings from SIRROUND-H and SIRROUND-T Trials Presented for the First Time at the 2016 ACR/ARHP Annual Meeting (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 16, 2016 Category: Pharmaceuticals Source Type: news

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids
Researcher stressed that most children born to women with the autoimmune condition not at risk for seizures Source: HealthDay Related MedlinePlus Pages: Children's Health, Epilepsy, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 16, 2016 Category: Consumer Health News Source Type: news

PRECISION: Differences Emerge Between RA and OA Patients PRECISION: Differences Emerge Between RA and OA Patients
Patients with rheumatoid arthritis (RA) and osteoarthritis (OA) respond differently to NSAIDs and COX-2 inhibitors, according to a subanalysis of data from the PRECISION trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2016 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Cumberland Pharma acquires U.S. rights to Nordic ’ s injectable methotrexate
Cumberland Pharmaceuticals (NSDQ:CPIX) said today that it acquired exclusive U.S. rights to Nordic Group‘s injectable methotrexate product line to treat rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriatic arthritis, and severe disabling psoriasis. Nordic Group has registered the product line for patient use in European countries, so Cumberland will register and commercialize the products in the U.S. Get the full story at our sister site, Drug Delivery Business News The post Cumberland Pharma acquires U.S. rights to Nordic’s injectable methotrexate appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - November 16, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Business/Financial News Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Cumberland Pharmaceuticals Nordic Group Source Type: news

Moms' Rheumatoid Arthritis May Be Linked to Epilepsy Risk in Kids
WEDNESDAY, Nov. 16, 2016 -- Some children born to mothers with rheumatoid arthritis may have higher-than-average odds of developing epilepsy, a new study suggests. Children born to mothers with rheumatoid arthritis were one-third more likely to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 16, 2016 Category: Journals (General) Source Type: news